Taniguchi M, Sato A, Mita H
    
    
    Front Allergy. 2023; 4:1145809.
  
  
    PMID: 38026126
    
          PMC: 10667677.
    
          DOI: 10.3389/falgy.2023.1145809.
      
 
                                  
  
    Cousins K, Chen C, Sehanobish E, Jerschow E
    
    
    Adv Pharmacol. 2023; 97:423-444.
  
  
    PMID: 37236766
    
          PMC: 10591515.
    
          DOI: 10.1016/bs.apha.2022.12.002.
      
 
                                  
  
    Jenerowicz D, Szyfter-Harris J, Mietkiewska-Leszniewska D, Czarnecka-Operacz M, Wierzbicka M, Adamski Z
    
    
    Postepy Dermatol Alergol. 2022; 39(3):617-619.
  
  
    PMID: 35950106
    
          PMC: 9326928.
    
          DOI: 10.5114/ada.2021.103305.
      
 
                                  
  
    Sillanpaa S, Numminen J
    
    
    Front Allergy. 2022; 2:659887.
  
  
    PMID: 35387049
    
          PMC: 8974786.
    
          DOI: 10.3389/falgy.2021.659887.
      
 
                                  
  
    Lyly A, Laidlaw T, Lundberg M
    
    
    Front Allergy. 2022; 2:734733.
  
  
    PMID: 35387030
    
          PMC: 8974777.
    
          DOI: 10.3389/falgy.2021.734733.
      
 
                              
              
                              
                                      
  Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges.
  
    Tabassum T, Rahman A, Araf Y, Ullah M, Hosen M
    
    
    Beni Suef Univ J Basic Appl Sci. 2022; 11(1):20.
  
  
    PMID: 35155689
    
          PMC: 8817645.
    
          DOI: 10.1186/s43088-022-00204-4.
      
 
                                          
                                                          
  NSAID-exacerbated respiratory disease: a population study.
  
    Andersen H, Ilmarinen P, Honkamaki J, Tuomisto L, Hisinger-Molkanen H, Backman H
    
    
    ERJ Open Res. 2022; 8(1).
  
  
    PMID: 35083326
    
          PMC: 8784895.
    
          DOI: 10.1183/23120541.00462-2021.
      
 
                                          
                                                          
  The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children.
  
    Gaffin J, Castro M, Bacharier L, Fuhlbrigge A
    
    
    J Allergy Clin Immunol Pract. 2021; 10(2):397-408.
  
  
    PMID: 34863928
    
          PMC: 8837696.
    
          DOI: 10.1016/j.jaip.2021.11.016.
      
 
                                          
                                                          
  Lung function and side effects of Aspirin desensitization: a real world study.
  
    Heikki T, Anu L, Annina L, Jura N, Elina P, Sahlman J
    
    
    Eur Clin Respir J. 2021; 8(1):1869408.
  
  
    PMID: 33520120
    
          PMC: 7808387.
    
          DOI: 10.1080/20018525.2020.1869408.
      
 
                                          
                                                          
  Monoclonal Antibodies and Airway Diseases.
  
    Lyly A, Laulajainen-Hongisto A, Gevaert P, Kauppi P, Toppila-Salmi S
    
    
    Int J Mol Sci. 2020; 21(24).
  
  
    PMID: 33322143
    
          PMC: 7763928.
    
          DOI: 10.3390/ijms21249477.
      
 
                                          
                                                          
  NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.
  
    Laidlaw T, Levy J
    
    
    Curr Allergy Asthma Rep. 2020; 20(4):10.
  
  
    PMID: 32172365
    
          PMC: 7192310.
    
          DOI: 10.1007/s11882-020-00905-9.
      
 
                                          
                                                          
  Disappearance of angina attacks after administration of mepolizumab.
  
    Imai K, Ochiai H
    
    
    BMJ Case Rep. 2019; 12(11).
  
  
    PMID: 31694826
    
          PMC: 6855881.
    
          DOI: 10.1136/bcr-2019-230219.
      
 
                                          
                                                          
  Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.
  
    Shah S, Abuzeid W, Ponduri A, Pelletier T, Ren Z, Keskin T
    
    
    Int Forum Allergy Rhinol. 2019; 9(12):1401-1408.
  
  
    PMID: 31569308
    
          PMC: 6901758.
    
          DOI: 10.1002/alr.22418.
      
 
                                          
                                                          
  Effects of Palm Oil Tocotrienol-Rich Fraction (TRF) and Carotenes in Ovalbumin (OVA)-Challenged Asthmatic Brown Norway Rats.
  
    Zainal Z, Abdul Rahim A, Khazaai H, Chang S
    
    
    Int J Mol Sci. 2019; 20(7).
  
  
    PMID: 30974772
    
          PMC: 6480080.
    
          DOI: 10.3390/ijms20071764.
      
 
                                          
                                                          
  Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management.
  
    Li K, Lee A, Abuzeid W
    
    
    Med Sci (Basel). 2019; 7(3).
  
  
    PMID: 30884882
    
          PMC: 6473909.
    
          DOI: 10.3390/medsci7030045.
      
 
                                          
                                                          
  Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease.
  
    Laidlaw T
    
    
    World J Otorhinolaryngol Head Neck Surg. 2018; 4(3):162-168.
  
  
    PMID: 30506046
    
          PMC: 6251957.
    
          DOI: 10.1016/j.wjorl.2018.08.001.
      
 
                                          
                                                          
  NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs.
  
    Dona I, Barrionuevo E, Salas M, Laguna J, Agundez J, Garcia-Martin E
    
    
    Sci Rep. 2018; 8(1):16710.
  
  
    PMID: 30420763
    
          PMC: 6232098.
    
          DOI: 10.1038/s41598-018-34668-1.
      
 
                                          
                                                          
  The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
  
    Comhair S, Bochenek G, Baicker-McKee S, Wang Z, Stachura T, Sanak M
    
    
    Respir Res. 2018; 19(1):210.
  
  
    PMID: 30376852
    
          PMC: 6208044.
    
          DOI: 10.1186/s12931-018-0909-6.
      
 
                                          
                                                          
  Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease.
  
    Feldman J, Zeigler A, Nelson K, Morales-Raveendran E, Pelletier T, Roizen G
    
    
    J Asthma. 2018; 56(7):731-738.
  
  
    PMID: 29972652
    
          PMC: 6467719.
    
          DOI: 10.1080/02770903.2018.1490754.
      
 
                                          
                                                          
  Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
  
    Philpott C, Sunkaraneni S, Wilson A, Erskine S, Philpott C, Clark A
    
    
    Respir Res. 2018; 19(1):129.
  
  
    PMID: 29945606
    
          PMC: 6020303.
    
          DOI: 10.1186/s12931-018-0823-y.